Formulation, Characterization, and Preliminary In Vitro Evaluation of LetrozoleIncorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells

Current Pharmaceutical Design · Published 2026-07-25 · DOI 10.2174/0113816128474280260720051151

Authors (4)

Muhammet Ali Polat, Kadir Aykaç, Zerrin Cantürk, Ebru Başaran

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Polat, M., Aykaç, K., Cantürk, Z., et al. (2026). Formulation, Characterization, and Preliminary In Vitro Evaluation of LetrozoleIncorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells. Current Pharmaceutical Design. https://doi.org/10.2174/0113816128474280260720051151

Related articles